Bacteria resisting medicine of erythrocin nanometer-emulsion and the preparing method
A technology of antibacterial drugs and nanoemulsions, applied in the field of medicine, can solve the problems of drug efficacy, side effects, and price differences, and achieve the effects of simple preparation methods, low toxicity, and high safety
Inactive Publication Date: 2007-09-12
NORTHWEST A & F UNIV
View PDF0 Cites 5 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Although many erythromycin derivatives have emerged in recent years to overcome these shortcomings, they differ in varying degrees in terms of efficacy, side effects and prices.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0041] Embodiment 1 preparation drug concentration is the erythromycin nanoemulsion of 0.5%
[0042] Erythromycin 0.5g
[0043] Absolute ethanol 5.0g
[0044] Tween-80 15.0g
[0045] Ethyl acetate 2.2g
[0046] Distilled water 78.3g
Embodiment 2
[0047] Embodiment 2 preparation drug concentration is the erythromycin nanoemulsion of 0.5%
[0048] Erythromycin 0.5g
[0049] Absolute ethanol 5.0g
[0050] Tween-80 15.0g
[0051] Ethyl acetate 5.0g
[0052] Distilled water 74.5g
Embodiment 3
[0053] Embodiment 3 preparation drug concentration is the erythromycin nanoemulsion of 1%
[0054] Erythromycin 0.5g
[0055] Absolute ethanol 5.0g
[0056] Tween-80 15.0g
[0057] Ethyl acetate 2.2g
[0058] Distilled water 27.3g
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
| Property | Measurement | Unit |
|---|---|---|
| Particle size | aaaaa | aaaaa |
| Particle size | aaaaa | aaaaa |
| The average particle size | aaaaa | aaaaa |
Login to View More
Abstract
The nanometer antibacterial erythromycin medicine consists of erythromycin in 0.5-1.5 wt% and nanometer emulsion matrix in 98.5-99.5 wt%. It is yellowish transparent liquid, and has medicine granularity of 1-100 nm, low viscosity, high stability, fast absorption, targeted medicine release, high bioavailability, less toxic side effect and other features. The medicine may be attached well onto bacteria and permeated into bacteria to disturb their metabolism and to reach bacteriostasis and bactericidal effect. It is used mainly for treating serious infection caused by penicillin resisting staphylococcus aureus and hemolytic streptococcus as well as chicken's chronic respiratory tract disease, malignant rhinitis, etc. The medicine has simple preparation process, less toxicity and high safety.
Description
technical field [0001] The invention belongs to the field of medicine and relates to a new dosage form of an antibacterial drug, in particular to an erythromycin nanoemulsion antibacterial drug and a preparation method thereof. Background technique [0002] Erythromycin is a macrolide antibiotic, mainly used for severe infections caused by drug-resistant Staphylococcus aureus and hemolytic streptococci, such as pneumonia, sepsis, endometritis, mastitis, etc.; Chronic respiratory diseases, mycoplasma pneumonia also have a good effect. It is not only used in human medicine, but also has broad application prospects in veterinary medicine. However, the traditional dosage form of erythromycin is easily destroyed by gastric acid when taken orally, and a considerable amount is also inactivated in the liver, resulting in a large dosage, short half-life in the body, frequent administration, and obvious gastrointestinal reactions. Although many erythromycin derivatives have emerged ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K31/7048A61K9/107A61P31/04
Inventor 欧阳五庆芮亚培
Owner NORTHWEST A & F UNIV

